Oncopeptides AB (publ) (FRA:OND)

Oncopeptides AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	147.92	178.54	173.41	344.52	362.19	840.26
Short-Term Investments	-	-	0.03	0.35	2.11	12.23
Cash & Short-Term Investments	147.92	178.54	173.44	344.86	364.3	852.48
Cash Growth	-40.84%	2.94%	-49.71%	-5.33%	-57.27%	-7.96%
Accounts Receivable	35.02	7.29	2.19	0.67	11.87	-
Other Receivables	-	6.24	15.68	16.25	24.01	11
Receivables	35.02	13.53	17.87	16.92	35.89	11
Inventory	8.43	4.37	2.43	-	-	8.67
Prepaid Expenses	-	6.19	5.43	1.71	7.42	8.96
Other Current Assets	0	9.96	3.73	0.54	4.76	13.69
Total Current Assets	191.37	217.08	202.9	364.03	412.37	894.8
Property, Plant & Equipment	19.91	27.11	34.63	20.44	24.74	38.33
Other Intangible Assets	-	-	-	-	1.41	1.83
Long-Term Deferred Tax Assets	-	-	-	-	-	8.18
Other Long-Term Assets	-	-0	0.85	0.85	0.85	3.62
Total Assets	211.28	244.19	238.38	385.32	439.38	946.76
Accounts Payable	12.24	18.17	15.03	28.22	35.7	136.14
Accrued Expenses	-	15.12	20.38	17.24	36.61	150.27
Current Portion of Leases	-	7.27	5.13	6	10.99	12.43
Current Income Taxes Payable	-	1.73	0.58	0.3	0.05	3.05
Current Unearned Revenue	-	0.07	0.5	-	-	-
Other Current Liabilities	43.74	4.66	3.32	33.91	141.94	52.52
Total Current Liabilities	55.97	51.36	44.93	85.67	225.29	354.4
Long-Term Debt	126.2	121.89	106.49	-	-	-
Long-Term Leases	22.57	12.55	19.67	-	3.21	6.93
Other Long-Term Liabilities	0	4.11	10.51	5.36	0.01	8.53
Total Liabilities	204.74	189.91	181.6	91.03	228.51	369.86
Common Stock	23.91	23.91	10.51	10.48	8.37	7.55
Additional Paid-In Capital	-	5,684	5,414	5,403	4,982	3,919
Retained Earnings	-	-5,651	-5,366	-5,116	-4,778	-3,348
Comprehensive Income & Other	-17.37	-2.84	-2.2	-2.3	-0.92	-1.54
Shareholders' Equity	6.54	54.29	56.78	294.29	210.87	576.9
Total Liabilities & Equity	211.28	244.19	238.38	385.32	439.38	946.76
Total Debt	148.77	141.72	131.29	6	14.19	19.36
Net Cash (Debt)	-0.85	36.82	42.15	338.86	350.11	833.13
Net Cash Growth	-	-12.65%	-87.56%	-3.21%	-57.98%	-8.58%
Net Cash Per Share	-0.00	0.22	0.47	4.12	4.65	13.36
Filing Date Shares Outstanding	272.71	215.19	94.6	94.31	75.29	67.94
Total Common Shares Outstanding	272.71	215.19	94.6	94.31	75.29	67.94
Working Capital	135.39	165.73	157.97	278.36	187.08	540.4
Book Value Per Share	0.02	0.25	0.60	3.12	2.80	8.49
Tangible Book Value	6.54	54.29	56.78	294.29	209.46	575.07
Tangible Book Value Per Share	0.02	0.25	0.60	3.12	2.78	8.46
Machinery	-	16.46	16.1	15.99	14.42	19.94

Source: S&P Global Market Intelligence. Standard template. Financial Sources.